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In 1921 Litzenbergl~pplied the term missed abortion to all
cases of death of the fetus in utero before viability with no
effort at expulsion within the usual time of an ordinary abortion,
the expulsion considered occurring up to 8 weeks after death.
Eastman, 1961, defines a missed abortion as the retention,
two months or more after its death, of an early intra-uterine
pregnancy.
Litzenberg states that in his cases hemorrhage 'V,as a prominent finding, giving the ovum a hemorrhagic a:fJpearance; but
hemorrhage may be entirely absent.

He noted that in the placenta

infarcts were numerous, sometimes occupying neal°ly the whole
organ, suggesting the probable cause of fetal death.

One of the

great dangers of missed abortion, he thought, was due to degeneration of the blood vessel walls which could be so completely
destroyed that uncontrollable hemorrhage could occur.

Disap-

pearance or marked diminution of the amniotic fluid without
rupture of the membrane was the rule.
He noticed the frequency of discrepancy between the size
of the placenta

~~d

the fetus, the former being often as large

as the placenta of a fetus a month or more older than the one
found.

This was considered to be due to connective tissue

increase, hemorr1">..age into the placenta and a curious true growth
of the placenta after the death of the fetus.
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He felt that when

the fetus died, especiallY in the early weeks, the chorion and
decidua may go on growing because they are nourished by the
maternal blood circulating in the intervillous spaces which may
continue for a long time.

LaVerge observed karyokinesis indi-

cating cell multiplication rather than hypertrophy.

He noticed

that the inner layer of the villous epithelium, which is not in
direct contact with maternal blood, is an early victim to coagulation necrosis; but the outer syncytial layer, bathed in maternal blood, is preserved much longer until thrombosis takes place
shutting off the blood supply to the intervillous spaces.

In

the second half of pregnancy Von Franque asserted that this
interesting phenomenon of continued growth after the death of
the fetus did not occur.

Microscopic studies showed all stages

of necrosis of tissue, placenta, decidua, amnion, blood vessels.
the fetus and even uterine walls.

If the

o~~

remained in the

uterus for a long time, drying out or mummification occurred.
By

Litzenberg's definition, the symptoms of miSsed abortion

are lack of increase in size of the uterus, cessation of fetal
movements and other signs of pregnancy.
the breasts also take place.

Regression changes in

Hemorrhage is a very inconstant

accompaniment of missed abortion, but in some form or another it
usually complicates the condition, sometimes constituting a
great danger.
Eastmanlbviews the cases of missed abortion as follows.
He states that in the typical instance, the first few months of
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pregnancy are completely normal:

amenorrhea. nausea and vom-

iting. breast changes, and gro",th of uterus.

All goes well

until the ovum dies, when there mayor may not be vaginal bleeding or even sY".llptoms denoting a threatened abortion, which subside.

It is then noted that the uterus seems to remain sta-

tionary in size and the breasts regress.
to lose a fe"t pounds in \<leight.

The patient is likely

Careful palpation and. measure-

ment of the uterus reveal the fact that it has not only ceased
to enlarge but is growing smaller, from the absorption of
amniotic fluid and maceration of the fetus.

Most patients are

symptomless during this period, except for the persistence of
amenorrhea.

Some, ho,.,ever, complain of lassitude and depress ion.

If the missed abortion terminates spontaneously, as most do, the
process of expulsion is quite the same as in any ordinary abortion.

The product, if reta.ined several weeks after fetal death.

is a shrivelled sac containing a highly macerated embryo, and
if retained for months or years, i t appep..I's to be a mass of old
tissue and blood with areas of dense calcification.

He states

that the cause of missed abortion is not known •
.:L

N. E. Borglin (Sweden) stated in 1957, that there is
nothing essential to distinguish

~issed

abortion with a demon-

strable embryo from an abortion occurring after more than 8
weeks in which the embryo has been absorbed.

The duration of

retention is often difficult to assess because it is not easy

and is often impossible to decide whether the embryo

t~s

died.

The strikingly large number of ordinary abortions suggests
that a missed abortion is only a variety of ordinary abortion.
It is suggested that the term missed abortion be reserved for
fetal death after the fourth month of pregnancy with retention
of the dead fetus for at least six weeks.

~~ny

prefer con-

servative treatment, in other words, waiting for a spontaneous
abortion, especially because of the risk of hemorrhage in surgical intervention, which is partly due to the frequently poor
contractile power of the uterus in this condition.

This inad-

equate power of contraction probably also causes retention
of the dead ovum.

Spontaneous abortion usually occurs ,,!ith

only slight loss of blood. because at this stage the vessels
of the uterine endometrium have thrombosed and the uterus has
recovered its power of contraction.

The severe loss of blood

on surgical evacuation of the uterine cavity and the copious
bleeding sometimes accompanying spontaneous abortion, can
occasionally be ascribed in part to hypofibrinogenemia.
The characteristic features of a missed abortion are
considered as low spontaneous myometrial activity, low oxytocin sensitivity and danger of bleeding after surgical intervention mainly due to atony, but sometimes to afibrinogenemia.
In view of the inactive state of the myometrium, which is often
thin and fragile, and of the successful estrogen treatment of
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a big

gr~~p

of missed abortions, it is felt that it is justi-

fied to conclude that lack of estrogen is an etiologic factor.
rt

Cassmer has

sho~m

that when the fetus dies and the placenta

is undamaged, the conditions predispose to mis.sed abortion.

On

the basis of these findings, i t was hypothesized that human
spontaneous missed abortion is due to fetal death and the consequent changes in the hormone production of the relatively undamaged placenta.

]'or a time after fetal death, the myometrium

remains progesterone dominated (Stage 1), and effective activity
cannot develop.

Sooner or later, placental hormone production

ceases; and bein.g devoid of both hormones, the myometrium is
"castrated" (or at least "non-pregnant") a.'1d unable to work
(Stage 2).

Estrogen domination will not occur until the myo-

metrium is again stimulated by estrogen, either produced by the
ovaries or given therapeutically.
to its treatment.

The etiology provides a clue

In Stage 1. treatment with estrogen and oxy-

tocin has no effect.

Destruction of placental function alone

(e.g. by intrauterine injection of hypertonic solution) removes
the progesterone block.
may not be necessary.

Estrogens may be useful, though they
Stage 2. estrogen alone usually starts

the abortion a.'1d surgical intervention is rarely necessary.
The validity of this theory of the etiology and treatment
of missed abortion was tested by these workers in thirteen consecutive patients.

To accelerate abortion in seven of the thir-

teen patients, oxytocin was given as an I.V. drop.

The purpose

of estrogen treatment in Stage 2 was to build up a potent
myometrium from a, IIcastrated" state and this necessarily
takes several days.

The estrogen, therefore, should be con-

tinued for 6 - 10 days.

If abortion has not occurred after

ten days, the hormonal state should be rechecked.
Their hypothesis of missed abortion was supported by
the fact that two stages. characterized by different hormonal
condition, could be distinguished and that selected treatment
Was successful on all yatients.
Roland\oticed that almost all patients who aborted had
falling or 10'" urinary hormone excretion before the onset of
bleeding or other disturbances.

When the preconceptional

endometrium showed poor premenstrual secretory activity and
urinary hormone excretions were correspondingly low, substitutional endocrine therapy during pregnancy appeared to salvage
a sizable percentage of pregnancies.
endometrium sho1rled poor secretory

When the preconceptional

~tctivity

and normal levels

of urinary hormone excretion, endocrine treatment during pregnancy had no effect.

When urinary hormone excretion levels,

particularly those of estrogen and pregnanediol were normal at
onset of bleeding, percentage of pregnancies with a favourable
outcome was much greater.

Workers who feel that a considerable

percentage of spontaneous abortion is due to maternal factors.
have found hormone determinations of substantial importance.
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Cassmer reported in 1959 that in therapeutic abortions
in mid-pregnancy he ruptured the membranes and pulled down
the umbilical cord, which was ligated and cut.

The foetus

and the placenta were left in the uterus for three days and
then they were removed tll.l"ough the cervix.

In these cases

with "isolated placentae" the urinary excretion of estrogens
decreased rapidly.

Three days after fetal death the urinary

estrogens had fallen to )0% of their previous value, and the
estrogens in the placenta had disappeared.

Some workers be-

Heve that the fetus may be responsible for estrogen production.

On the other hand, pregnanediol fell much less and

after three days, the output 'vas still 87% of the previous
value.

During these three days no uterine activity was ob-

served.

This indicates that if the foetus dies before the

placenta, the production of estrogen ceases before that of
progesterone.

Because Cassmer removed the whole conceptus

after three days, we do not

kno~l

from his studies how rapidly

and to what levels the production of estrogen and progesterone
may fall later.
When the fetus and placenta die simultaneously, as in
saline-induced abortions, the placental production of estrogen and progesterone falls rapidly and simultaneously.

The

withdrawal of progesterone which affects only the excitability
of the myometrium, acts more quickly than does the withdrawal
of estrogens, which has the slower task of building up the
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myometrium.

Then, when placental function is abruptly des-

troyed. the effect of progesterone on the myometrium is dominated by estrogen for a timeCIi'ig. 1).
Fig. 1
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Under these conditions, contractions start and abortion is
rapidly completed, thus, missed abortion does not develop.
The mechanism must be similar in spontaneous abortions where
fetal death is a consequence of placental death.

On these

findings was based the hypothesis that human spontaneous
missed abortion is due to fetal death and the consequent
changes in the hormone production of the relatively undamaged
placenta.

For a time after fetal death the myometrium re-

mains progesterone dominated, and effective activity cannot
develop.

Sooner or later placental hormone production ceases;

and, being devoid of both hormones, the myometrium is virtually
"ca.strated ll and unable to ,",ork.
Dr. M. Doyle states that daily determinations of the
urinary excretion of pregna.nediol and estriol before and after
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intrauterine death in missed abortion showed that estriol
excretion falls well before pregnandiol excretion.

If the

hypothesis is correct, two stages of missed abortion should
be found:
Stage 1.

with a progesterone dominated myometrium resulting
from partial functioning of the placenta, and
characterized by slight reduction of pregnanediol
and greater reduction of estrogen excretion.

Stage 2.

in which the myometrium is "castrated," characterized by severe reduction of both estrogen and
pregnanediol excretion.

It is not

kno~n

how long after fetal death, placental pro-

gesterone production can be maintained.

The time after fetal

death, therefore. does not necessarily indicate in which sta.ge
a case is.
The hormonal function of the placenta in missed abortion
is not fully UIJ.derstood.

Pregnancy tests. based on the chor-

ionic gonadotrophins in the urine. are often negative but
sometimes positive.

The excretion of urinal'S pregnanediol

is often 10\>1 but occasionally normal or only slightly reduced.
The urinary excretion of estrogen is very low, thus the hormonal function of the placenta, judged by the urinary excretion
of these three hormones, is often severely impaired, though
occasionally this impairment is only slight.
i'ff.>.....

Stouffer and

Asch~rorth

believe that patients with intra-

uterine retention of a dead fetus are potentia.l ca,.Y1didatea for

9

development of hypofibrinogenemia.

This disease results from

a consta.nt process of laying o.own of fibrin in the intervillous
spaces of the placenta in the dead fetus syndrome and from
local deposition of fibrin at the site of placental separation
in cases of

abr1~tio

placenta.

Beginning \,lith the third \I,reek after apparent fetal death,
the concentration of fibrinogen in the plasma should be determined weekly.

It is postulated that the fetus that is at least

thirteen weeks old. can develop the condition of hypofibrinogenemia.

If the concentration of fibrinogen falls below

50 mg./100 ml., the uterus should be emptied prorL1ptly.

At

least 4 grams of human fibrinogen and several units of compatible whole blood should be immediately availa,ble.

After

emptying the uterus, close attention should be given to blood
loss,from the

vagir~.

Present evidence. however, indicates

that once the uterus is empty the process of defibrination
ceases and hemostasis can be maintained without further adminiater of fibrinogen.
i~

Zielinska (Poland, 1958) found four cases of hypofibrinogenemia in 20 pregnant women with a dead fetus.
olysins were also found.

Ji'ibrin-

These usually appe8.red four weeks

after the moment of death of the fetus.

The behavior of fibrin-

ogen and fibrinolysin levels in these women is characteristic.
The fibrinogen level may remain high despite the presence of
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fibrinolysins.

Thanks to which the hypofibrinogenemia does

not appear as often.

During labor a considerable decrease

in fibrinogen level takes place.

After three hours, the level

increases and after 24 hours it returns to normal.
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PROGESTERONE AND PROGESTATIONAL AGENTS
The main actions of progesterone are directed toward
preparation of the uterus for reception of the fertilized
ov~

and maintenance of a favorable environment for its growth

arA development.

Studying the biosynthesis and metabolism of

progesterone and its interrelations with other steroid hor-

s

mones, Plotz and Davis (Univ. of Chicago) found that cholesterol
of two sources is available in an endocrine gland for synthesis of progesterone:

(1) cholesterol synthesized within

the endocrin gland and (2) plasma cholesterol, which is derived
from dietary cholesterol and cholesterol synthesized in the
liver. the rate of absorption of plasma cholesterol by the
corpus luteum and placenta was found to be efficient and rapid.
Progesterone itself is not excreted into the urine, but its
principal metabolite, pregr>...anediol, appears in large and. increasing amounts in the urine of pregnant women, reaching peak
values of 70-90 mg./24 hours during the last part of the third
trimester.

Pr egnaPAl one , another metabolite of progesterone,

follows a similar excretion pattern.

Progesterone secreted

into the circulation from the glands disappears rapidly from
the blood.

Similarly, when progesterone is administered I.M.

the hormone and/or its metabolites diffuse promptly from the
blood circulation intc the fat compartment of the body.
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These

findi!1gs explain (1) the failure of large doses of progesterone injected I.M. to raise the blood level of progesterone
and the ra.pid disappearance of progesterone from the blood
after I. V. injection and (2) the delayed excret ion of progesterone metabolites after I.V. injection.
if:-

The sources of endogenous progesterone are as follows:

The ovaries, the adrenals, and in pregnancy the placenta are
the sites of progesterone production in the female.
The progesterone produced in the ovary comes primarily
from the corpus luteum.

The follo'tling biochemical results

are presented as evidence (1) The relatively large a."'Ilounts
of progesterone in human corpora lutea of the menstrual cycle
and of pregnancy, (2) The increased pregnanediol excretion
after formation of the corpus luteum, as well as the drop in
pregnanediol after physiological repression or removal of
the corpus luteum.
Through the work of Rechter, it is known that progesterone occupies a key position in the 'biosynthesis of the
adrenal cortical hormones.

This does not necessarily mean

that the adrenal cortex must secreter;>rogesterone, however,
indication that secretion of the hormones may occur
for some time.

~AS

existed

Olear cut evidence for the production of pro-

gesterone by human adrenal cortex was presented by Short,
through the demonstration of progesterone in adrenocortical
venous blood after AOTH stimulation.
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There is no question now tr.at the human ple,centa produces progesterone.

With the grollJth of the placenta. the pro-

gesterone production increases.

Experi~ental

evidence is:

(1) Presence of progesterone in placental tissue at all
phases of gestation;
(2) Increase in progesterone concentration in arm vein
blood during pregnancy, with rapid decrease after removal of
the placenta;

(3) Increase in pregnanediol excretion during pregnancy.
Rapid decrease follows removal of the placenta;

(4) Increase in pregnanediol concentration in the arm
vein blood during pregnancy;
(5) Increased :progesterone levels in fat tissue during

pregnancy;

(6) Yaintenance of pregnancy with abnormal pregnanediol
excretion after removal of the corpus leteum or of the ovaries
in early pregnancy;

(7) ~ro initial change of pregnanediol excretion after
operative removal of an abdominal pregnancy, the placenta
being left in situ.

After expulsion of the placenta in a

normal delivery, pregnanediol excretion drops

i~tediately;

(8) Uo cr.ange of pregnanediol excretion after artifie:ially

induced fetal death with the placenta left in situ.

Rapid de-

crease following removal of the placenta;
(9) Normal pregnanediol excretion in Addison's disease or
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following bilateral adrenalectomy; thus the adrenals are not
the main source of progesterone.
(10) Higher levels of progesterone in the uterine venous
blood than in peripheral venous blood at the end of pregnancy;
(11) Higher levels of progesterone in the umbilical venous
blood than in the blood of the umbilical arteries;
(12) Presence of progesterone in a chorion epithelioma;
(1)) Conversion of ~5

- pregnen.olone to progesterone by

placental tissue in vitro;
(14) Conversion of A 5 - pregnenolone and cholesterol to
progesterone in pla.centalperfusion experiments.

Effects of Progesterone on Endometrium
The withdrawal of progesterone near term has been thought
by many workers to be a factor for the onset of labor.

Although

few dispute the relaxing effect of progesterone on the myometrium, the diminution either of progesterone in the blood or of
its

meta~olic

products in the urine near labor has never been

well established.

In vitro studies in human pregnant and non-

pregnant myometrium have revealed that the

i~~ibiting

action of

progesterone can be antagonized if enough oxytocin is added in
the muscle bath.

On the other hand oxytocin stimulated con-

tractions can be abolished if enough progesterone is added.
Concernir~

the action of the progesterone on the end om-
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etri~n.

It

Erux noted:

(a) The appearance of glycogen in the

basal part of the cells of the glands (lucid zone) later at
the apical part; (b) The forrmation of connective spindles with
cellular "puffsll \,/hieh give a lacy aspect to the glands; (c)
Oellular modification of the endometrial stroma, evidenced by
a widening of the cytoplasm of the fibroblastic and reticular
cells, especially in the superficial zone; Cd) and, surro~~ding
these, grad.ually formed coiled arteries.
These endometrial transformations appear progressively
follow'ing ovulation, reaching their maximum at the 26th day of
the cycle , with glycogen in pools in the lumen of the tubes and
the appearance of a mucoid secretion in the cells.

Hemorrhagic

ruptures, marked edema and an invasion of polymorphonuclear
leucocytes are the expression of the very near
the endometrium.

brea~ing

down of

Progesterone will produce certain morphologic

changes in the endometrium only if there is adequate estrogen
stimulation.
A group of workers"..in New York did cytological

e~~inations

of the smears of surgical castrates under estrogen and progesterone therapy.

They found that the cell types are often more

highly proliferated than usual in the luteal phase of the normal
menstrual cycle.

It was not an infrequent finding in patients

under hormone therapy that some parts of the endometrium shovled
more marked secretory

c~~ges

tr~n

others.

The endometrial specimens ,..,rere taken
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t1tJO

,..,reeks after the

commencement of progesterone therapy, and the histological
findings were classified into the following four groups.
(1) Proliferative changes only;
(2) Minimal evidence of secretory change.

Several glands

exhibited no evidence of secretory change. whereas gome of the
glands show subnuclear vacuolization with central position of
nuclei;

(3) Early secretory changes (delayed for the time of
administration of progestational agents - 14 days).
all glands show the follo,,,ing features:

Practically

a. subnuclear vac-

uolization, b. central position of the nuclei, c. supranuclear
vacuolization, d. minimal evidence of accumulated secretion,
e. relatively sharp nuclear border at the gland lumen, and f.

early tortuosity of the glands;

(4) Late secretory

ct~nges

(compatible with the late

luteal changes of the normal menstrual cycle).
glands show the following features:
nuclei;

Practically all

a. basal position of the

b. supranuclear vacuolization of the cytoplasm;

warked accumulation of glandular secretion;
cellular borders with
lumen and;

Il

c.

d. loss of sharp

melting" of the cytoplasm into the gland

e. well-developed. tortuosity of the gland.

The 19-nor steroids have been widely used for OVUlation
inhibition.

Twenty day courses of the 19-nor steroid combined

with an estrogen are currently being employed.
several reports about the endometrial
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char~es

There have been
induced by the cyclic

administration of these compounds.

With norethynodrel there

is a very early appearance of glandular secretion similar to
that seen in the early part of the normal luteal phase.

Ro'Y'-

ever, after the appearance of intraepithelial vacuolization.
the glands cease to progress and instead become small, involuted,
and inactive in appearance.

The stroma becomes markedly ede-

matous, with variable degrees of pseudo-decidual reaction.

Rice-

Wray and others have studied the effects produced by the cyclic
a~ministratial

of norethindrone, and also emphasize the regres-

sive changes and irregularity of glandular secretion.
both compounds advanced atrophy has been observed.

VHth

Surpris-

ingly, these endometria have a remarkable capacity to rebound
imnlediately to functional and histologic normalcy once treatment is stopped.
Some of the events which take place during the normal
cyclic evolution of the endometrium are as follows:

glandular

gro\lrth and tortuosity increase gradually reaching a maximum
in the last quarter of the cycle.

Secretory changes which

begin on day 16, reach a peak on day 19 and 20, and then regress
rapidly during the next two days.

In the meantime stromal edema

makes its appearance and pseudodecidual cranges become apparent.
The sequence of events during therapy with norethynodrel is
glandular regression iflhich seems to appear by day 14-16 and
glandular regressive changes are far advanced by day 21.

There

is an almost complete disappearance of secretion by day 19-21
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except in an occasional isolated gland.

Stromal edema is quite

marked from the outset and becomes intense at day 19-21.

Pseu-

dodecidual change begins to appear about day 21, and remains
patchy and low in its degree of development.
markedly similar to

tr~t

This is a reaction

of progesterone.

j

:Barnes states that such im:portant differences between the
myometrium of one area contrasted with the myometrium of another
area indicates that the uterus throughout most of pregnancy cannot act as a unit.

In contrast to the remainder of the myomet-

rium, the muscle benea.th the placenta apparently has a relative
paralysis, a factor which may contribute to the fact that premature separation of the placenta is a comparatively rare accident rather than being a common place cliC1.ical phenomenon.

In

seeking an explanation for such differences, it would be quite
logical to postulate that the placenta itself contributed the
differentiating factor and that some placental ingredient permeated the myometrium locally and altered its chemical composition
and hence its contractile ability.
Since it has been demonstrated in the estrogen treated
animal that the administration of progesterone will elevate the
resting membrane potential as well as the total tissue potassium
of the myometriu.rn, the postUlate has been advanced that placentally
produced or stored progesterone reaches the cells of the adjacent
myometrium in greater concentration than it reaches the rest of
the

myometr~~

contributing to this relative paralysis.

19

This

hypothesis gains support from the recent documentation of the
effect of progesterone on other huraan smooth muscle.

It has

suffered, however. from the fact that endogenous progesterone
has never been recovered from the myometrium by any of the
previously available techniques.
statement that

11

Zander makes the specific

it has never been possible to demonstrate

nonlabeled progesterone or either of the A4_ 3- ketopregneneaI-one isomers in the target tissues, uterine muscles, and
mucosa. II

Using labeled progesterone, Davis and Plotz and

Zander indicated that only a very limited amount of administered hormone is present in the muscles (eleven to eighteen
weeks of pregnancy).
Using gas-liquid phase chromatography, a technique has
been developed for measuring tissue progesterone levels.
Because this procedure requires fewer preliminary steps in
purification and extraction, the placental levels found have
been approximately twice those previously reported. and human
myometrium from the term or near-term pregnant uterus has been
found to have a concentration of progesterone varying from
0.05 to 0.63

micrograL~s

per gram wet weight tissue.

Norethynodrel, a 19-nortestosterone derivative, has
three main properties:

(1) Progestational action when admin-

istered orally; (2) Inherent estrogenic effects and (3) Inhibition of the pituitary gland.
endometrium.

It has been

It has a unique action on the

thOl~ht
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to exert a progesterone effect

on the human endometrium without estrogenic priming, although
it has been uncertain whether all components of the endometrium
reacted similarly to the compound.
The following experiments were done on normally ovulating
12

patients:

Ten patients were given 10 mg. daily from the 4-24

day of the cycle.

]'or the most part, the glands were arrested

in the early follicular phase, with some showing slight dilatat ion in some patients with normal ovulatory cycles.

The

glands were lined with either high or low columnar epithelium,
with a minimum amount of secretion.
poorly.
some

The cytoplasm stained

The stroma was cellular, with sOme edema.

hemorrl~ic

areas.

There were

Five patients were given 10 mg. daily

from 12-30 days of the cycle.

The response of the endometrium

was different when norethynodrel was started (at) near the midcycle.

The glands, arrested at the late proliferative phase,

became dilated and cystic.

The epithelium was flattened be-

cause of the intraluminal pressure.
edematous.

The stroma was markedly

There "lere no changes in the blood vessels.

Even though the endometrial glands are arrested in the
early proliferative phase, treatment of patients ,,,ith secondary
amenorrhea will result in withdrawal bleeding in most cases.
Norethynodrel appears. therefore. to exert es trogen and progesterone effects on the endometrium.

This effect is limited to

the strorr.a. and less so to the epithelium.
,i

Goldzieher says that perhaps the greatest clinical concern
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about synthetic progestational steroids has been the possibility
of masculinization of female fetuses in mothers treated early in
pregnancy for threatened or habitual abortion.

Unfortunately,

the statistical bias inherent in the collection of "anecdotal fl
data makes it difficult to interpret the results.

Any conclusion

of the causal relationship between hormonal therapy and fetal
masculinization based on this ty-pe of information may result in
another expJnple of post hOc' fallacy.

Several instances of

clitoral hypertrophy have been observed by the author in newbOr!l i:nfants of mothers who received no hormone thera.py.

Other

cases of maSCUlinization have been reported in women who have
received only stilbestrol, an estrogen which is not even a
steroid.

Such observations argue more for spontaneous occur-

rence than for any causal relationship_
not improbable

t~~t

It therefore, seems

fetal anomalies in women treated with

synthetic progestins reflect the current therapeutic vogue
rather than any causal relationship between the steroid and the
anomaly.

To date, no case of human fetal masculinization in

women treated \'dth medroxyprogesterone has been reported despite
the widespread use of this material.
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REVIEW OF CASES OF POSSIBLE MISSED ABORTION
FOLLOWING TREATl\iJENT OF T:a:B:ElATENED ABORTIG1T
WITH

PROGEST.ATlm~AL

AGEt-ITS

In the treatment of threatened abortion with various
progestational agents and progesterone some cases of what
appear to be missed abortions have occurred.

These patients,

after being treated folloidng an episode of vaginal bleeding
and a period of lov,Ier abdominal cramping, have been observed
to show discontinuation of increase in the size of the uterus
and of the other signs of pregnancy that were present previously.

It has been postulated that the treatment with uro-

gestational agents may in some unexplained manner lead to the
death of the fetus in utero, or that the fetus is already dead
and the agents affect the uterine motility.

The fetus is

retained like tr.a.t of a missed a.bortion to be terminated by
natural expulsion or dilatation and curettage.

The following

consists of a series of cases reported. by various doctors in
Omaha, Nebraska.
Case 1
A 30 year old Negro female, para 3-1-4-4,

~~

about

4-2-62 was admitted to UNH on 7-5-62 with the chief complaint
of vaginal bleed.ing, uterine cramping a.nd possible passage of
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tissue.
I.lil.

She was treated with bedrest and Depo-Provera 75 mgm.

She was given 100mgm. of the Depo-Provera on the follow-

ing d.ay.

The vaginal bleeding and cramping gradually subsided.

A past history revealed menarehe at 13 years old. regular 28 day
menstrual cycle with no dysmenorrhea.

In 1948 she had a term

baby, 1953 - 8 month gestation, 1956 - term, 1957 - aborted at
6-7 weeks, 1959 - aborted at 3 months, 1960 - term, 1961 aborted at 3 months.

On 7-10-62 she again complained of

cra~pYt

aching pain belo,,, the umbilicus and extending laterally \.,ith
lumbar region pain.

She had a pinkish vaginal discharge.

She

began to flow again on 11-10-62 lasting three days and spotted
until 12-5-62 at which time she was bleeding heavily.

She was

considered a missed abortion after being seen in the emergency
room and a D and C was done.

The pathological report showed a

piece of cotyledon and hyalinized necrotic material
Case 2
A 30 year old para 3 gravida 7 abortions 3 with
on 8-21-62.

She was first seen on 12-7-62 with an episode of

profuse vaginal
Provera.
tation.

Uv~

bleedi~~

followed by spotting.

She was given

On 1-4-63 the uterus was the size of 3-4 months gesThere was no quickening and occasional bleeding occurred.

On 1-29-63 there still was no growth of the uterus.
Provera was stopped.

She no longer felt pregnant.

the uterus \-ras still the 3-4 month gestation size.
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At this time
On 2-18-63
The fibrinogen

level was 250

mg.%

on 2-14-63 and 350

was done on 3-2-63.

mg.%

on 2-27-63.

A DandC

Pathology report showed a macerated fetus,

about 8 weeks gestation with a necrotic placenta.
Case 3
A 39 year old. white female. para 0000, married 19 years,
with

L~~

on. 12-10-62.

She has had a regular 28 day menstrual

cycle with bleeding lasting three days since menarche.
test was positive in January.
ruary_

A frog

She began to spot in early Feb-

About seven days later a flow like a normal menstrual

period occurred

a~d

lasted three days.

She was given a pro-

gestational agent and the bleeding stopped.

In

~2Ich

there was

no increase in uterine size, and the pregnancy test was negative.
An abdominal hysterotomy was done on

3-12~63.

The material

removed was placental along with a 2 month gestation fetus both atrophic and fibrous.
Case 4
A 43 year old white female became pregnant after a long
history of

i~Jertility.

She began to bleed vaginally and was

placed on Depo-Provera 100 mgm. I.1-1. on August 31, at which time
she was also taking sulfa.

She received Depo-Provera again on

November 17, November 24, and December 8.
bloody mucus on January 30. 1963.
noted on January 29.

She had passage of

Last fetal movements were

On 4-5-63 a D and C was performed

ischemic necrosis in decidual tissue was found.
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a~d

Past history

involved two abortions in 1960 and 1961.
Case 5
A 27 year old white female para lOll, L:!<1P 12-62, EDC
9-15-63 with thrombocytopenic purpura and a history of a missed abortion in 1960 with a D and 0 following 5 weeks of
bleeding.

On 2-5 the fundus measured 8-10 cm. on 2-25 she

was bleeding vaginally, the cervix was closed, fundus at
10 cm and she

,\18.$

placed an Depo-Provera 100 mgm. r .14.

3-13 the fundus '''as llcm and she

~las

On

again given 100 mgm.

of Depo-Frovera.

On 3-27 - fundus 12 cm. 1;:i th one episode

of spotting.

,1fas

She

given Depa-Provera 100 mgm.

fundus 12 cm. - another 100 mgm. of Depo-Provera.
there "las questionable uterine enlargement.
ered a missed abortion.
on 4-30.

She

On 4-8
On
~las
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consid-

The pregnancy test became negative

A D and C ,\,laS done on 5-3.
Case 6

A 27 year old. para 1001 - LMP 1-7-63.
4-9-63 for vaginal spotting.
Ent CVP plus

Prover~.

~~y.

W8.S

trea,ted "lith

The uterus had not increased in size

since the previous visit.
a week through

On 4-23 she

She '''as seen on

She was also on Deluteval twice

On 5-30 she

r~d

an episode of severe

vaginal bleeding with possible passage of tissue.

The uterus

was estimated to be the size compatible with two months gestation.

A D and C was done and necrotic decidual and placental
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tissu.e "las found without a fetus.
Case

7

A" 26 year old, para 1021, LMP December

1959. with a

history of previous abortions in l-1a,rch 1959 and August 1959.
In December she thought that she was pregnant and was given

15 shots of progesterone in an attempt to prevent another
abortion.

She ha.d an episode of bleedil"..g in April, but it

d.id not seem like a period.
April 18, 1960.

She r...a.d complete amenorrhea since

She didn't feel good a..'1d was given thyroid.

extract 1 grain for one year.

She "ras considered a possible

missed abortion because of the "shots. 1I
test was negative.

She "Jas given progesterone and bled on

the t\tJelfth day after injection.
passed tissue.

In October the frog

On 10-27-60 she bled and

A D and C "las done.

The pathology report

indicated an incomplete abortion with fibroses and degeneration
in the placenta.
Case 8
A 22 yet>..I' old ",hite female,para. 0110,

Ene

2-3-63.

L~lP

4-27-62,

She was seen on 8-2-62 for pressure on the bladder,
~out

cramping and passing blood and a large clot.

She ';las

40 mgm. orally of Provera the following day.

She had SOme

bleedir>..g every day since then \vi th occasional cramping.

on

She

stated tlmt the time of bleeding coincided with the fourth
period since her LMP.

At the time of the second period she had
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cre-nrps but no bleeding.
8-13-62.

Pregnancy tests were negative on

A D and C was done on 8-17-62 and a macerated fetus

and placenta. were removed.
Case

9

A 26 year old white female. para 3002, 1M? 9-5-62.

noticed spotting since 11-22-62.
of Depo-Provera.

She

She was treated with 100 mgm.

She was seen on 1-5-63.

The uterus which

should have been the size of four months gestation was the size
of a. two month gestation.

She no longer felt pregnant.

was diagnosed as a missed abortion.

She

A D and C was done on

1-22-63 sho\tling degenerated decid.ual tissue and chorionic villi.
The following cases are presented to illustrate the production of' what appears to be a. missed abortion after treatment
of a threatened abortion with agents other than progestational
agents.
Oase 10
A 23 year old \tlhi te female para lOll,
felt quickening on 3-2-58.
void.ing.

Iu\rjp

11-1l.J-57.

On 3-9 she began spotting following

She \-!as placed on. Lutrexin 2000 and 3-4 xd.

bro\li'11ish spotting recurred on 1+-4.

On 5-9

ther~

dence of uterine gro\ith since the previous month.
a D and E was performed.

She

The

",as no eviOn 5-29

There was escape of bro1!mish amniotic

flu:i.d and minimal bleeding. no fetus and evidence of hydropic
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degeneration.

Microscopic examination showed. pla.centa. decidual

and endometrium of early pregnancy with hydatiform deformity of
villi.
Case 11
A 37 year old \'(I1".i te female, para 7007, LlvIP 4-14-63, EC

1-21-64, t'(lith a mens trual cycle of 20-23 days las ting four cla.ys.
On 7-19-63 she was hospitalized as a threatened abortion.

She

was placed on Stilbestrol 25 mgm. three times a day, DUO-aVp
t"Jice a day.

On 8-22-63 there was no bleeding or uterine

enlargement.

She "ras diagnosed as a. missed. abortion.

A

D and C wa.s done on 8-30 and necrotic placental and decidual
tissue Was found.
Case 12
A 43 year old white female, para 2012,

k'~

1I?as seen on 4-15-55 after spotting for one week.
the pregnancy test was positive.
Stilbestrol every four hours.

2-7-55.

She

At this time

She was placed. on 25 mg.

On 6-13 the uterus was soft

and. irregular but not the size of a four month pregnancy.

The

pregnancy test ''las negative.

She l:'.ad spotting and cramping on

7-15 which lasted until 8-11.

A D and E was done on 8-13 and

i t sho,"red a. placenta with necrosis, hehlorrb.age and acute infla-

mmation and she was considered a missed abortion.

Her past. his-

tory included a. cesearean section done for placenta previa in

1949. and a. miscarriage in 1952, a.lso, two possible miscarriages

29

in :/'.lB.rch 1953 and July 1953.

A D and C Was done for a

hydatitiforn mole in August 1953.

The majority of cases were treated, at the time that
s-potting \'las noted,

'tli

th a progestational agent in the attempt

to salvage the pregp.ancy from aborting.

The bleeding usually

subsided \>li thin a short period of time.

However, instead of

proceeding on to a full term viable pregnancy the growth of
the uterus and the other signs of pregnancy subsided and within
four to ten weeks bleeding usually recurred and a dilatation
and curettage wa.s done on the basis of a diagnosed missed abortion.

The ages and parities of the patients differed.

Some of

the patients had histories of previous a.bortions as well as
missed abortions.

Very fe'V! of them were on any other medication

besides the progestational agents ee.rly in the pregnancy or a.t
the time of treatment.

According to the accepted definition of

missed abortion, it is difficult to determine whether the treatment of a threatened abortion, as occurred in the above ca.ses,
with progesterone could cause a missed abortion to take place.
The evidence seems to support the suspicion that it does possibly occur.

Further research into the subject is necessary be-

fore any proof against the use of the progestational agents in
such cases can be considered.
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SUMMARY

The danger in the use of :9X'ogesta.tional agents in the
treatment of threatened abortions is considered.

A hypothesis

is put forth that the type of treatment may in some way lead
to the development of a missed abortion.

T\tlelve cases are

reviewed in which treatment ""ith a progestational agent was
begun when the patient began to spot early in the pregnancy_
In each of these cases, in the ensuing weeks, a missed abortion
developed and a D and C was necessary for removal of the necrotic
products of gestation.
above thesis.

No direct proof Was set forth in the

This is considered only as a possibility to be

considered in the use of progestational agents.

As a preview

to the case reports the various aspects of missed abortion were
reviewed.

A missed abortion was defined, according to Eastman,

as the retention, two months or more after its death, of an
early intra-uterine pregnancy.
the etiology.

There were no decisions as to

The relationship between blood levels of proges-

terone and estrogen along. "J1th the urinary excretion of pregnanediol and estriol before

a~A

a£ter uterine death was examined.

Several workers have noticed the fall in fibrinogen levels of
women carrying dead fetuses.

They have also noted tha,t in spite

of high levels of fibrinolysins the fibrinogen levels did not
fall in direct proportion.

The danger occurred during labor
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when cases of severe bleeding did result.
The general properties and area of production in the body
of progesterone was cited.

The action of progesterone in preg-

nancy and its effects on the endometrium were discussed.
actions of norethynodxel were included here.
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The

COUCLUS I 01T

A hypothesis is presented in this thesis that the use of
progestational agents in treating t:b..reateneo. abortions may be
responsible for its developing into a missed abortion.

These

agents, in some way. may be the cause of death. of the fetus and
decrease in the size of the pregnant uterus.

This is not to be

used as proof in any way that this occurs. but is written to
increase the index of suspicion when these drugs are used.
Further extensive research, using controls, is necessary for
proof that there is a direct relationship between the use of
progesterone and the development of a missed abortion.
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